There is 1 paper on markers of liver fibrosis in aging research: 1 trial in people.
1 paper studies it9 more mention it
3 new papers in 30 daysSee all 10 papers on markers of liver fibrosis
- Human trial1
Latest
5 papers in 12 monthsJournal of Extracellular Vesicles
Circulating Liver-Derived and CD36⁺ Extracellular Vesicles Correlate With Ectopic Liver Fat and Markers of Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Decrease During Weight Loss Intervention
Non-randomized trial in peopleLiver fat content
Nutrition, Metabolism, and Cardiovascular Diseases
Fibrosis-4 index and all-cause mortality in MASLD/NAFLD and cardiometabolic populations: a systematic review with structured synthesis without meta-analysis (SWiM)
Meta-analysis of observational studiesFibrosis-4 Index
ESC Congress 2026 Abstract
Dynamic changes in liver fibrosis and the risk of death and bleeding in non-cirrhotic patients with atrial fibrillation treated with NOACs
Cohort study of 733 peopleLiver fibrosis
Naunyn-Schmiedeberg's Archives of Pharmacology
Anti-inflammatory versus metabolic therapy in MASLD: a randomized clinical trial of aspirin and dapagliflozin using fibroscan outcomes
Randomized trial in 80 peopleAspirin
BMC Gastroenterology
Development of a liver stiffness measurement-based nomogram model to identify early CKD risk in patients with MAFLD
Cohort study of 1,328 peopleLiver stiffness measurement
Geriatrics & Gerontology International
The Role of an Elevated Fibrosis-4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease
Cross-sectional study of 384 peopleMetabolic dysfunction-associated steatotic liver disease
Hepatology Research
Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus
Non-randomized trial in 16 peopleTirzepatide
Journal of Diabetes and Metabolic Disorders
Association between liver fibrosis and osteoporosis in adults aged 50 and older: insights from the Bushehr Elderly Health Program
Cross-sectional study of 1,959 peopleLiver fibrosis
European Journal of Pharmaceutical Sciences
Activation of SIRT1 by SRT1720 alleviates dyslipidemia, improves insulin sensitivity and exhibits liver-protective effects in diabetic rats on a high-fat diet: New insights into the SIRT1/Nrf2/NFκB signaling pathway
Experiments in ratsDyslipidemia